1578957: RETAPLASE,RECOMBINANT FOR INJECT.
RETAPLASE,RECOMBINANT FOR INJECT. Key specifications include part_name_assigned_by_controlling_agency: RETEPLASE, INTRAVENOUS SOLUTION KIT, 2 VIALS(10 UNITS PER VIAL). This part is cataloged in the U.S.
Government catalog under NSN 6505-01-477-6768, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | RETEPLASE, INTRAVENOUS SOLUTION KIT, 2 VIALS(10 UNITS PER VIAL) |
| NSN | 6505-01-477-6768 |
| SPECIAL FEATURES | RETAVASE IS A TISSUE PLASMINOGEN ACTIVATOR (TPA) INDICATED FOR TREATMENT OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) TO REDUCE THE RISK OF DEATH AND HEART FAILURE; LYOPHILIZED POWDER KIT FOR IV INJECTION; CONTAINS: 2 SINGLE-USE RETAVASE 10-UNIT VIALS; 2-SINGLE-USE PREFILLED STERILE WATER FOR INJECTION; 2 SYRINGE PLUNGERS; 2 STERILE 10ML GRADUATED SYRINGES; 2 STERILE RECONSTITUTION SPIKES; 1 QUICK REFERENCE GUIDE AND 1 PACKAGE INSERT; BOX SHOULD REMAIN SEALED TO PROTECT THE LYOPHILISATE FROM EXPOSURE TO LIGHT. STORE KIT AT 2 TO 25 DEGREES CELSIUS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | RETEPLASE, INTRAVENOUS SOLUTION KIT, 2 VIALS(10 UNITS PER VIAL) |